DE69016129T2 - Vakzin gegen Escherichia coli. - Google Patents

Vakzin gegen Escherichia coli.

Info

Publication number
DE69016129T2
DE69016129T2 DE69016129T DE69016129T DE69016129T2 DE 69016129 T2 DE69016129 T2 DE 69016129T2 DE 69016129 T DE69016129 T DE 69016129T DE 69016129 T DE69016129 T DE 69016129T DE 69016129 T2 DE69016129 T2 DE 69016129T2
Authority
DE
Germany
Prior art keywords
toxin
coli
strains
vaccine
flagella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69016129T
Other languages
German (de)
English (en)
Other versions
DE69016129D1 (de
Inventor
Den Bosch Johannes Francis Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69016129D1 publication Critical patent/DE69016129D1/de
Publication of DE69016129T2 publication Critical patent/DE69016129T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69016129T 1989-08-18 1990-07-23 Vakzin gegen Escherichia coli. Expired - Lifetime DE69016129T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (2)

Publication Number Publication Date
DE69016129D1 DE69016129D1 (de) 1995-03-02
DE69016129T2 true DE69016129T2 (de) 1995-05-24

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69016129T Expired - Lifetime DE69016129T2 (de) 1989-08-18 1990-07-23 Vakzin gegen Escherichia coli.

Country Status (16)

Country Link
US (1) US5750115A (https=)
EP (1) EP0413378B1 (https=)
JP (1) JP3031561B2 (https=)
KR (1) KR0177510B1 (https=)
CN (1) CN1062605C (https=)
AU (1) AU635062B2 (https=)
CA (1) CA2022420C (https=)
DE (1) DE69016129T2 (https=)
DK (1) DK0413378T3 (https=)
ES (1) ES2070266T3 (https=)
GR (1) GR3015782T3 (https=)
HU (2) HU210965B (https=)
IL (1) IL95175A (https=)
NZ (1) NZ234933A (https=)
TW (1) TW204353B (https=)
ZA (1) ZA906100B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
WO1998051217A1 (en) * 1997-05-16 1998-11-19 Medical Defense Technologies, Llc Vaccine against lipopolysaccharide core
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
IL139538A0 (en) * 1998-05-15 2004-02-08 Mkb Invest Ltd Partnership Compositions and method for immunizing poultry
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
JP5085547B2 (ja) * 2005-08-30 2012-11-28 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 生理活性ポリペプチドの細菌性送達
CA2781866C (en) 2009-10-12 2019-12-03 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
CN102905522A (zh) 2009-10-12 2013-01-30 新健康科学股份有限公司 用于从红细胞中除去氧的氧消耗装置和方法
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9339025B2 (en) 2010-08-25 2016-05-17 New Health Sciences, Inc. Method for enhancing red blood cell quality and survival during storage
PT2635114T (pt) 2010-11-05 2020-06-16 New Health Sciences Inc Irradiação de glóbulos vermelhos e armazenamento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
ES2984863T3 (es) 2011-08-10 2024-10-31 Hemanext Inc Dispositivo integrado de filtrado de leucocitos, oxígeno y/o agotamiento de CO2, y separación de plasma
ES2900298T3 (es) 2013-02-28 2022-03-16 Hemanext Inc Dispositivo de agotamiento de gas para productos sanguíneos
PT3970731T (pt) 2015-03-10 2026-02-24 Hemanext Inc Kits descartáveis de redução de oxigénio, dispositivos e métodos de utilização dos mesmos
WO2016172645A1 (en) 2015-04-23 2016-10-27 New Health Sciences, Inc. Anaerobic blood storage containers
CA2985799A1 (en) 2015-05-18 2016-11-24 New Health Sciences, Inc. Methods for the storage of whole blood, and compositions thereof
KR20240132129A (ko) 2016-05-27 2024-09-02 헤마넥스트 인코포레이티드 혐기성 혈액 저장 및 병원체 불활성화 방법
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
EP0237045B1 (en) * 1986-03-11 1993-10-20 Shionogi & Co., Ltd. DNA encoding flagellin and vector having the same

Also Published As

Publication number Publication date
HU210965B (en) 1995-09-28
EP0413378A1 (en) 1991-02-20
AU635062B2 (en) 1993-03-11
NZ234933A (en) 1992-06-25
US5750115A (en) 1998-05-12
CA2022420A1 (en) 1991-02-19
IL95175A (en) 1994-05-30
EP0413378B1 (en) 1995-01-18
CN1049523A (zh) 1991-02-27
JP3031561B2 (ja) 2000-04-10
ZA906100B (en) 1991-05-29
GR3015782T3 (en) 1995-07-31
HU211827A9 (en) 1995-12-28
DK0413378T3 (da) 1995-05-15
TW204353B (https=) 1993-04-21
AU6109990A (en) 1991-02-21
CN1062605C (zh) 2001-02-28
HUT59612A (en) 1992-06-29
DE69016129D1 (de) 1995-03-02
ES2070266T3 (es) 1995-06-01
KR0177510B1 (ko) 1999-03-20
JPH03184996A (ja) 1991-08-12
CA2022420C (en) 2000-03-28
KR910004209A (ko) 1991-03-28
HU905053D0 (en) 1991-01-28
IL95175A0 (en) 1991-06-10

Similar Documents

Publication Publication Date Title
DE69016129T2 (de) Vakzin gegen Escherichia coli.
EP0633313B1 (de) Impfstoff gegen die Lyme-Krankheit
DE69423383T2 (de) Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
DE69012318T2 (de) Impfstoffe gegen hämophilus influenzae.
DE69231619T3 (de) Methode und Zusammensetzung zur Verhütung der Lyme-Krankheit
Verstreate et al. Outer membrane proteins of Brucella abortus: isolation and characterization
DE69032806T2 (de) Verfahren zur isolierung und reinigung von rezeptoren für transferrin und lactoferrin von bakterien und herstellung von impfstoffen, die sie enthalten
DE69333036T2 (de) DNA-Fragmente, die für die Untereinheiten von dem Neisseria Meningitidis Rezeptor kodieren
DE69333028T2 (de) Deletionsmutanten als impfstoffe gegen cholera
DE69110082T2 (de) Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae.
DE69635783T2 (de) Antigen omp26 aus haemophilus influenzae
DE69432658T2 (de) Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
DE69332243T2 (de) Hochmolekulare oberflächen-proteine des nicht-typisierbaren hämophilus
DE3882781T2 (de) Impfstoff gegen Pasteurella.
DE69110997T2 (de) Haemophilus Paragallinarum-Impfstoffe.
DE3856240T2 (de) Herstellung der p1 proteine und impfstoffe gegen gonorrhöe
DE69634003T2 (de) Hybrid-moleküle aus hitzelabilem enterotoxin und choleratoxin-b-untereinheiten
EP0519218A2 (de) Hybrid-Plasmid für 38 kDa Antigen von M. Tuberculosis, E. coli als Wirt, 38 kDa Antigen und etwa 33 kDa Protein
DE69226944T2 (de) Darstellung und verwendung von mit formalin abgetöteten e. coli bakterien, die das kolonie-faktor-antigen (cfa) expremieren zur impfung gegen das die darminfektion/diarrhoe in menschen auslösende darmbakterium e. coli
DE69535422T2 (de) Vakzin für einen nicht typisierbaren Haemophilus influenzae Stamm
DE68926427T2 (de) Vom streptococcus m-protein abgeleitete synthetische peptide und damit hergestellte impfstoffe
US5593679A (en) Poultry vaccine against E. coli air sac inflammation and septicaemia
DE69835522T2 (de) Das 74 kilodalton protein der äusseren membran von moraxella catarrhalis
DE69032014T2 (de) Impfstoff gegen schweinedysenterie mit vermindertem gehalt an proteinuntereinheit
DD295553A5 (de) Impfstoff gegen die lyme-krankheit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL